Phio Pharmaceuticals reports promising Phase 1b trial results for PH-762, showing complete tumor clearance in two patients with no significant adverse effects.

While technology is sometimes a hit-or-miss affair, particularly with the intrusions of innovation occasionally outweighing its conveniences, the best pharmaceutical stocks typically enjoy ...

As 2024 ends with market turbulence, the pharmaceutical sector is emerging as a beacon of stability and growth, with this stock leading the pack. The Nifty50 index recorded a commendable gain of ...

Shares of pharma stocks emerged as outliers in a weak market, with prominent names like Dr Reddy's Labs, Cipla, and Lupin rising 1-4 percent on December 19. Other stocks, including Laurus Labs ...

We recently compiled a list of the Jim Cramer Talked About These 8 Stocks. In this article, we are going to take a look at where Royalty Pharma plc (NASDAQ:RPRX) stands against the other stocks ...

Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). If you are looking for stocks that are well ...

All ten analysts who have coverage on Piramal Pharma have a "buy" recommendation on the stock. JM Financial's price target of ₹340 is also the highest on the street for Piramal Pharma, followed by ...

Today, as we search for an upcoming stock-split candidate, we can consider a major pharmaceutical company that sells one of the world's most in-demand products. Will this company announce a stock ...

Equity benchmarks ended higher on Friday, marking their second consecutive session of gains, as pharmaceutical and automobile stocks led the advance amid subdued trading volumes ahead of the year-end.